On April 29th, Emelie Gezelius successfully defended her PhD thesis titled “Coagulation and other aspects of the cardiovascular system in small cell lung cancer” at the Lecture Hall of the Radiotherapy building. The defense was well attended by family, friends, and colleagues and the audience was delighted by the outstanding presentation.

On her project, Emelie had the supervision of Mattias Belting, and the co-supervision of Hans Brunnström. As faculty opponent, Professor Bjørn Henning Grønberg from the Norwegian University of Science and Technology lead a thorough and interesting discussion.

The thesis focused on the roles and consequences of coagulation activation and other aspects of cardiovascular stress in patients with small cell lung cancer (SCLC) and the research yielded several important findings, such as that low-molecular-weight heparin did not improve survival in SCLC and the prophylactic use of it cannot be recommended in the general management of SCLC, as it was performed.

Emelie's work has been highly praised and her research will be an invaluable resource for future research.

Congratulations to Emelie on her successful defence!